Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Nature Communications|February 15, 2022
Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activityKarolina Piekarska, Zuzanna Urban-Wójciuk, Małgorzta Kurkowiak, et al.Diabetes, Obesity & Metabolism|April 20, 2022
Combined therapy with CD4+ CD25highCD127- T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trialMaciej Zieliński, Magdalena Żalińska, Dorota Iwaszkiewicz-Grześ, et al.Diabetes, Obesity & Metabolism|November 26, 2025
Safety and efficacy of the therapy with CD4 + CD25highCD127-T regulatory cells: When paediatric patient becomes adultMarta Bandura, Magdalena Piotrowska-Mieczkowska, Matylda Hennig, et al.Journal of Translational Medicine|December 2, 2016
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetesNatalia Marek-Trzonkowska, Małgorzata Myśliwiec, Dorota Iwaszkiewicz-Grześ, et al.BMJ Open Diabetes Research & Care|February 27, 2020
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapyMateusz Gliwiński, Dorota Iwaszkiewicz-Grześ, Anna Wołoszyn-Durkiewicz, et al.International Immunopharmacology|March 30, 2024
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity ameliorationMaciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz-Grześ, et al.Scientific Reports|March 5, 2026
Decreased potential for lymphatic vessel generation is a hallmark of early diagnosed arterial hypertension and can be reversed by treatment with angiotensin converting enzyme inhibitorsMateusz Gliwiński, Tomasz Koliński, Zuzanna Urban-Wójciuk, et al.Pageof 9